Posts

Vinay Prasad Details New Approach to COVID-19 Vaccine Approvals in Recent FDA Memos

Vinay Prasad Explains FDA's Revocation of Pfizer's Covid Vaccine EUA for Children

Vinay Prasad Returns to the FDA With Fewer Titles and a Lower Profile

FDA Seeks Greater Alignment Between CBER and CDER: Makary Informs Industry Leaders

Vinay Prasad Departs FDA Amid Conservative Criticism and Sarepta Gene Therapy Controversy

Vinay Prasad's First Major Policy: Challenging Covid Vaccine 'Dogma' at FDA

Vinay Prasads FDA Appointment Anything but Status Quo

Biotech stocks plunge and industry figures left to wonder after Prasad's FDA appointment